Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Times Interest Earned (2019 - 2025)

BridgeBio Pharma (BBIO) has disclosed Times Interest Earned for 7 consecutive years, with -$11.99 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned fell 14.21% to -$11.99 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.07 through Dec 2025, up 22.14% year-over-year, with the annual reading at -$9.86 for FY2025, 51.25% down from the prior year.
  • Times Interest Earned hit -$11.99 in Q4 2025 for BridgeBio Pharma, up from -$12.37 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $0.01 in Q1 2024 to a low of -$17.2 in Q1 2021.
  • Historically, Times Interest Earned has averaged -$8.13 across 5 years, with a median of -$8.04 in 2023.
  • Biggest five-year swings in Times Interest Earned: soared 100.23% in 2024 and later crashed 17047.93% in 2025.
  • Year by year, Times Interest Earned stood at -$10.94 in 2021, then surged by 40.92% to -$6.46 in 2022, then tumbled by 35.4% to -$8.75 in 2023, then decreased by 19.98% to -$10.5 in 2024, then dropped by 14.21% to -$11.99 in 2025.
  • Business Quant data shows Times Interest Earned for BBIO at -$11.99 in Q4 2025, -$12.37 in Q3 2025, and -$3.57 in Q2 2025.